| Name | tert-butyl 5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole-1-carboxylate |
|---|---|
| Synonyms |
5-methyl-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoimidazole-1-carboxylic acid tert-butyl ester
1-Boc-5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole tert-Butyl 5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate |
| Molecular Formula | C19H27BN2O4 |
|---|---|
| Molecular Weight | 358.24000 |
| Exact Mass | 358.20600 |
| PSA | 62.58000 |
| LogP | 3.42710 |
| HS Code | 2934999090 |
|---|
|
~%
631909-46-1
Detail
|
| Literature: 3-DIMENSIONAL PHARMACEUTICALS, INC. Patent: WO2003/99805 A1, 2003 ; Location in patent: Page 123 ; |
|
~50%
631909-46-1 |
| Literature: 3-Dimensional Pharmaceuticals, Inc. Patent: US2004/9995 A1, 2004 ; |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |